Global Real-World Evidence Solutions Market 2022 - Snapshot

August 2022 | 48 pages | ID: G279C0E8332DEN
Gen Consulting Company

Abstracts

In 2021, the global real-world evidence solutions market stood at USD 977 million. Recording a CAGR of 13.5% from 2022 to 2028, the worth is projected to reach ~USD 2,371 million by 2028, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the component, therapeutic area, end user, and region. The global market data on real-world evidence solutions can be segmented by component: data sets, services. Real-world evidence solutions market is further segmented by therapeutic area: cardiovascular disease, immunology, neurology, oncology, others. Based on end user, the real-world evidence solutions market is segmented into: healthcare payers, healthcare providers, pharmaceutical & medical device companies, others. On the basis of region, the real-world evidence solutions market also can be divided into: North America, Europe, Asia-Pacific, Rest of the World.

The global real-world evidence solutions market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Accenture plc, Clinigen Group Plc, COTA Inc., IBM Corporation, ICON plc, IQVIA Inc., Optum Inc., Oracle Corporation, Parexel International Corporation, PerkinElmer Inc., PPD Inc., Saama Technologies LLC., SAS Institute Inc., Syneos Health Inc., Tempus Labs Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Real-World Evidence Solutions Market
• Identify segments/areas to invest in over the forecast period in the Global Real-World Evidence Solutions Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. REAL-WORLD EVIDENCE SOLUTIONS MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY COMPONENT

Data sets
Services

PART 5. MARKET BREAKDOWN BY THERAPEUTIC AREA

Cardiovascular disease
Immunology
Neurology
Oncology
Others

PART 6. MARKET BREAKDOWN BY END USER

Healthcare payers
Healthcare providers
Pharmaceutical & medical device companies
Others

PART 7. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
Rest of the World

PART 8. KEY COMPANIES

Accenture plc
Clinigen Group Plc
COTA, Inc.
IBM Corporation
ICON plc
IQVIA Inc.
Optum, Inc.
Oracle Corporation
Parexel International Corporation
PerkinElmer, Inc.
PPD, Inc.
Saama Technologies, LLC.
SAS Institute, Inc.
Syneos Health, Inc.
Tempus Labs, Inc.

PART 9. METHODOLOGY